How to Help Your Patients Find Humulin N in Stock: A Provider's Guide

"My pharmacy doesn't have my insulin." If you manage patients on Humulin N, you have likely heard this at some point. When a patient calls your office in a panic about a missing insulin prescription, your team needs a clear, efficient protocol — both to protect patient safety and to manage your staff's time effectively.

This guide outlines a structured, step-by-step approach for your practice to help patients locate Humulin N when their usual pharmacy is out of stock.

Step 1: Triage the Urgency

When a patient contacts your office about a Humulin N stock problem, the first clinical question is: how much supply do they have left?

5+ days remaining: Non-urgent. Assist patient in locating another pharmacy or placing a special order. No prescription change needed.

1-4 days remaining: Urgent. Immediately direct patient to check nearby pharmacies (including OTC availability). Begin the alternative insulin discussion if no stock can be found within 24 hours.

Less than 1 day remaining or already out: Emergency. Provider must intervene directly. Issue prescription for Novolin N or an appropriate alternative. Document clearly in the patient's chart.

Step 2: Remind Patients About OTC Availability

One of the most underutilized facts about Humulin N is that it is available over the counter in most U.S. states — no prescription is required. It is kept behind the pharmacy counter. Your staff can relay this to patients:

Script for staff: "Humulin N is available without a prescription at most pharmacies — just ask the pharmacist directly. Walmart also carries it as ReliOn NPH insulin at a lower price. Call ahead to confirm your nearest pharmacy has it in stock before making the trip."

Step 3: Direct Patients to medfinder

Rather than having your staff call multiple pharmacies — which is time-consuming — direct patients to medfinder. medfinder calls pharmacies near the patient's location to check which ones have the medication in stock, then texts results back. This is faster for your patient and removes the burden from your office team.

Consider printing a small card with medfinder's URL (medfinder.com) to hand to insulin-dependent patients at every visit as a proactive resource.

Step 4: Offer to Transfer or Modify the Prescription

If the patient has found a pharmacy with stock but needs the prescription transferred, your office can call the prescribing pharmacy to facilitate the transfer. Alternatively, you can write a new prescription directly to the pharmacy that has the medication.

For patients who cannot find Humulin N at any accessible pharmacy, consider writing a bridging prescription for Novolin N — which is pharmacologically equivalent and OTC available. Document the reason in the chart.

Step 5: When to Prescribe an Alternative Basal Insulin

If no NPH insulin is available in the patient's area, transitioning to a long-acting analog is clinically appropriate. Key considerations:

Start glargine (Basaglar or Lantus) at 80% of total daily NPH dose, given once daily

Adjust prandial insulin regimen if the patient is on basal-bolus therapy, as the elimination of NPH's peak effect may alter postprandial control

Schedule a follow-up call within 5-7 days to review fasting glucose trends and titrate if needed

Discuss cost: Basaglar is covered under the Lilly Insulin Value Program ($35/month cap). Semglee (glargine biosimilar) may be lowest-cost on many formularies.

Preventing Shortage Situations: Proactive Prescribing Strategies

Consider implementing these strategies at your practice to reduce shortage-related crises:

Write 90-day prescriptions. Where insurance allows, 90-day supplies via mail-order pharmacy dramatically reduce how often patients must navigate retail inventory.

Authorize early refills. Add a DAW (dispense as written) note to enable refills at 75-80% supply remaining, particularly for insulin-dependent Type 1 patients.

Document a contingency plan. For every insulin-dependent patient, note in the chart which alternative insulin is clinically acceptable so staff can act quickly if a shortage call comes in.

Educate patients at each visit. Remind patients that Humulin N is OTC, that Novolin N is a close equivalent, and that medfinder can help them find stock quickly.

Bottom Line for Providers

Humulin N stock gaps are a manageable problem with the right systems in place. Triage by days of supply remaining, remind patients about OTC access and medfinder, and have an alternative insulin plan documented for each patient. medfinder.com/providers is a resource your patients can use to find available stock without calling your office. For a deeper dive on the clinical shortage picture, see: Humulin N Shortage: What Providers and Prescribers Need to Know in 2026.